pubmed-article:12560440 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12560440 | lifeskim:mentions | umls-concept:C1516238 | lld:lifeskim |
pubmed-article:12560440 | lifeskim:mentions | umls-concept:C0138741 | lld:lifeskim |
pubmed-article:12560440 | lifeskim:mentions | umls-concept:C0936223 | lld:lifeskim |
pubmed-article:12560440 | lifeskim:mentions | umls-concept:C0599161 | lld:lifeskim |
pubmed-article:12560440 | lifeskim:mentions | umls-concept:C0237881 | lld:lifeskim |
pubmed-article:12560440 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:12560440 | lifeskim:mentions | umls-concept:C0220901 | lld:lifeskim |
pubmed-article:12560440 | lifeskim:mentions | umls-concept:C0750502 | lld:lifeskim |
pubmed-article:12560440 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:12560440 | pubmed:dateCreated | 2003-1-31 | lld:pubmed |
pubmed-article:12560440 | pubmed:abstractText | To determine whether reverse transcriptase polymerase chain reaction (RT-PCR) to detect circulating prostate-specific antigen (PSA)-positive cells is a prognostic factor for survival in hormone refractory prostate cancer and to validate the prognostic importance of this test in relation to other known prognostic factors. | lld:pubmed |
pubmed-article:12560440 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12560440 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12560440 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12560440 | pubmed:language | eng | lld:pubmed |
pubmed-article:12560440 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12560440 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12560440 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12560440 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12560440 | pubmed:month | Feb | lld:pubmed |
pubmed-article:12560440 | pubmed:issn | 0732-183X | lld:pubmed |
pubmed-article:12560440 | pubmed:author | pubmed-author:VogelzangNich... | lld:pubmed |
pubmed-article:12560440 | pubmed:author | pubmed-author:KantoffPhilip... | lld:pubmed |
pubmed-article:12560440 | pubmed:author | pubmed-author:HayesDaniel... | lld:pubmed |
pubmed-article:12560440 | pubmed:author | pubmed-author:HalabiSusanS | lld:pubmed |
pubmed-article:12560440 | pubmed:author | pubmed-author:SmallEric JEJ | lld:pubmed |
pubmed-article:12560440 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12560440 | pubmed:day | 1 | lld:pubmed |
pubmed-article:12560440 | pubmed:volume | 21 | lld:pubmed |
pubmed-article:12560440 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12560440 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12560440 | pubmed:pagination | 490-5 | lld:pubmed |
pubmed-article:12560440 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:12560440 | pubmed:meshHeading | pubmed-meshheading:12560440... | lld:pubmed |
pubmed-article:12560440 | pubmed:meshHeading | pubmed-meshheading:12560440... | lld:pubmed |
pubmed-article:12560440 | pubmed:meshHeading | pubmed-meshheading:12560440... | lld:pubmed |
pubmed-article:12560440 | pubmed:meshHeading | pubmed-meshheading:12560440... | lld:pubmed |
pubmed-article:12560440 | pubmed:meshHeading | pubmed-meshheading:12560440... | lld:pubmed |
pubmed-article:12560440 | pubmed:meshHeading | pubmed-meshheading:12560440... | lld:pubmed |
pubmed-article:12560440 | pubmed:meshHeading | pubmed-meshheading:12560440... | lld:pubmed |
pubmed-article:12560440 | pubmed:meshHeading | pubmed-meshheading:12560440... | lld:pubmed |
pubmed-article:12560440 | pubmed:meshHeading | pubmed-meshheading:12560440... | lld:pubmed |
pubmed-article:12560440 | pubmed:meshHeading | pubmed-meshheading:12560440... | lld:pubmed |
pubmed-article:12560440 | pubmed:meshHeading | pubmed-meshheading:12560440... | lld:pubmed |
pubmed-article:12560440 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:12560440 | pubmed:articleTitle | Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in metastatic prostate cancer: a nested study within CALGB 9583. | lld:pubmed |
pubmed-article:12560440 | pubmed:affiliation | Department of Biostatistics and Bioinformatics and CALGB Statistical Center, Duke University, Durham, NC 27710, USA. susan.halabi@duke.edu | lld:pubmed |
pubmed-article:12560440 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12560440 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:12560440 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:12560440 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12560440 | lld:pubmed |